1st Quarter - Report
KADESH & ASSOCIATES, LLC for GENENTECH INC
Client
Income
$45,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 515 & H.R. 1260 - Patent Reform Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK KADESH | COS, Sen. Feinstein |
| CHRISTIAN KIERIG | LA, Sen. Feinstein |
Health Issues HCR
H.R. 1548 - Pathway for Biosimilars Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK KADESH | COS, Sen. Feinstein |
| CHRISTIAN KIERIG | LA, Sen. Feinstein |
Medicare/Medicaid MMM
Medicare issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK KADESH | COS, Sen. Feinstein |
| CHRISTIAN KIERIG | LA, Sen. Feinstein |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ROCHE HOLDINGS, LTD | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.